AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32282342 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 19546
Study 32282342 — intervention group
Group type: COMPARATOR
Intervention: Annual FIT
Number of subjects: 19546
Study 32282342 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual risk-adapted screening
Number of subjects: 19546
Study 33664334 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic exercise (AE)
Number of subjects: 0
Study 33664334 — intervention group
Group type: EXPERIMENTAL
Intervention: Burdock root extract (BE)
Number of subjects: 0
Study 33664334 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 0
Study 34086393 — intervention group
Group type: EXPERIMENTAL
Intervention: On-clamp RAPN
Number of subjects: 324
Study 34086393 — intervention group
Group type: COMPARATOR
Intervention: Off-clamp RAPN
Number of subjects: 324
Study 33545793 — intervention group
Group type: EXPERIMENTAL
Intervention: Assist/control (A/C) group
Number of subjects: 40
Study 33545793 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support ventilation (PSV) group
Number of subjects: 40
Study 33545793 — intervention group
Group type: EXPERIMENTAL
Intervention: Weaning index (WI) < 50.44
Number of subjects: 40
Study 33545793 — intervention group
Group type: EXPERIMENTAL
Intervention: Weaning index (WI) < 61.45 in A/C group
Number of subjects: 40
Study 33545793 — intervention group
Group type: EXPERIMENTAL
Intervention: Weaning index (WI) < 51.45 in PSV group
Number of subjects: 40
Study 34825898 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol (5-15 mg/day)
Number of subjects: 50
Study 34825898 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 34348539 — intervention group
Group type: EXPERIMENTAL
Intervention: VC-Free model
Number of subjects: 0
Study 34348539 — intervention group
Group type: EXPERIMENTAL
Intervention: VCI model
Number of subjects: 0
Study 34348539 — intervention group
Group type: EXPERIMENTAL
Intervention: UNI model
Number of subjects: 0
Study 34348539 — intervention group
Group type: COMPARATOR
Intervention: Placebo arm of VITALITY-ALS clinical trial
Number of subjects: 0
Study 36451771 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab
Number of subjects: 7410
Study 36451771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7410
Study 32068255 — intervention group
Group type: EXPERIMENTAL
Intervention: Original bortezomib dosing regimen
Number of subjects: 0
Study 32068255 — intervention group
Group type: EXPERIMENTAL
Intervention: Less frequent bortezomib dosing
Number of subjects: 0
Study 32068255 — intervention group
Group type: COMPARATOR
Intervention: Control arm of the ALCYONE clinical trial
Number of subjects: 0
Study 36426618 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated VR cognitive behavior therapy (VR‐CBT) app treatment (n = 77)
Number of subjects: 153
Study 36426618 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition (n = 76)
Number of subjects: 153
Study 33415649 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth self-management, shared care intervention
Number of subjects: 0
Study 33415649 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32497553 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium silicate and sodium phosphate toothpaste (CSSP)
Number of subjects: 247
Study 32497553 — intervention group
Group type: COMPARATOR
Intervention: Fluoride control toothpaste
Number of subjects: 247
Study 35259172 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive Caregiving Intervention
Number of subjects: 39
Study 35259172 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 39
Study 36175320 — intervention group
Group type: EXPERIMENTAL
Intervention: Restorative neurostimulation
Number of subjects: 204
Study 33934973 — intervention group
Group type: EXPERIMENTAL
Intervention: Active coping strategies
Number of subjects: 80
Study 33934973 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive coping strategies
Number of subjects: 80
Study 33934973 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of neuropathic pain
Number of subjects: 80
Study 33934973 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline VISA-A score
Number of subjects: 80
Study 33934973 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall outcome
Number of subjects: 80
Study 32891018 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal balance training with rhythmical auditory stimuli (RAS-supported intervention, n = 17)
Number of subjects: 35
Study 32891018 — intervention group
Group type: COMPARATOR
Intervention: Multimodal balance training without rhythmical auditory cues (n = 18)
Number of subjects: 35
Study 36377369 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPE intervention (social media groups with peer leaders)
Number of subjects: 300
Study 36377369 — intervention group
Group type: COMPARATOR
Intervention: Control group (social media groups without peer leaders)
Number of subjects: 300
Study 34016257 — intervention group
Group type: EXPERIMENTAL
Intervention: First appropriate ICD shock
Number of subjects: 5516
Study 34016257 — intervention group
Group type: EXPERIMENTAL
Intervention: Inappropriate shock
Number of subjects: 5516
Study 34016257 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD therapy for VT ≥200 beats/min or VF
Number of subjects: 5516
Study 34016257 — intervention group
Group type: EXPERIMENTAL
Intervention: Appropriate therapy for VT <200 beats/min or inappropriate therapy
Number of subjects: 5516
Study 34016257 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined assessment of all therapy and arrhythmia types
Number of subjects: 5516
Study 34016257 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 or more ICD appropriate shocks
Number of subjects: 5516
Study 32856073 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular flushing (5 flushes)
Number of subjects: 164
Study 35640009 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain educational video
Number of subjects: 77
Study 35640009 — intervention group
Group type: COMPARATOR
Intervention: No video (control group)
Number of subjects: 77
Study 32217042 — intervention group
Group type: EXPERIMENTAL
Intervention: Pop music
Number of subjects: 46
Study 32217042 — intervention group
Group type: EXPERIMENTAL
Intervention: Rock music
Number of subjects: 46
Study 32217042 — intervention group
Group type: EXPERIMENTAL
Intervention: Western Classical music
Number of subjects: 46
Study 32217042 — intervention group
Group type: EXPERIMENTAL
Intervention: Persian Traditional music
Number of subjects: 46
Study 32217042 — intervention group
Group type: COMPARATOR
Intervention: Silence
Number of subjects: 46
Study 36347196 — intervention group
Group type: EXPERIMENTAL
Intervention: VENT strategy (low-tidal-volume with positive end-expiratory pressure)
Number of subjects: 725
Study 36347196 — intervention group
Group type: COMPARATOR
Intervention: noV strategy (resting-lung strategy, no ventilation)
Number of subjects: 725
Study 36347196 — intervention group
Group type: EXPERIMENTAL
Intervention: VENT strategy
Number of subjects: 725
Study 33120301 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg kg−1 IV
Number of subjects: 126
Study 33120301 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg kg−1 IV and Magnesium 2 g IV
Number of subjects: 126
Study 33120301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 36380280 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of OK lens and 0.01% atropine eye drops
Number of subjects: 60
Study 36380280 — intervention group
Group type: COMPARATOR
Intervention: Combination of OK lens and placebo
Number of subjects: 60
Study 35777876 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-focused intervention including explicit elicitation of parental concerns, a prognostic algorithm to identify low-risk children, and provision of safety-netting advice printout.
Number of subjects: 336496
Study 35777876 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned in the abstract.
Number of subjects: 336496
Study 34006604 — intervention group
Group type: COMPARATOR
Intervention: Mailed letter about HCV screening (letter only)
Number of subjects: 21303
Study 34006604 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed letter with laboratory order for HCV screening (letter+order)
Number of subjects: 21303
Study 34006604 — intervention group
Group type: COMPARATOR
Intervention: Usual care content
Number of subjects: 21303
Study 34006604 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral science content
Number of subjects: 21303
Study 34006604 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed letter about HCV screening (for active patient portal users)
Number of subjects: 21303
Study 34006604 — intervention group
Group type: COMPARATOR
Intervention: Patient portal message with similar content (for active patient portal users)
Number of subjects: 21303
Study 32171426 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab, trastuzumab, and docetaxel
Number of subjects: 808
Study 32171426 — intervention group
Group type: COMPARATOR
Intervention: Placebo, trastuzumab, and docetaxel
Number of subjects: 808
Study 32388627 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentalization-based treatment in groups (MBT-G)
Number of subjects: 111
Study 32388627 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 111
Study 32308550 — intervention group
Group type: EXPERIMENTAL
Intervention: Figure‐of‐8‐Suture
Number of subjects: 290
Study 32308550 — intervention group
Group type: COMPARATOR
Intervention: Manual compression (control group)
Number of subjects: 290
Study 32308550 — intervention group
Group type: EXPERIMENTAL
Intervention: Figure‐of‐8‐Suture (in obese patients)
Number of subjects: 290
Study 32308550 — intervention group
Group type: COMPARATOR
Intervention: Manual compression (control group, in obese patients)
Number of subjects: 290
Study 33568144 — intervention group
Group type: EXPERIMENTAL
Intervention: Persian version of the celiac disease quality of life questionnaire (PCDQOL)
Number of subjects: 220
Study 33568144 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory factor analysis (EFA) and confirmatory factor analysis (CFA)
Number of subjects: 220
Study 33568144 — intervention group
Group type: EXPERIMENTAL
Intervention: PCDQOL compared with SF36 and self-rated QOL
Number of subjects: 220
Study 33568144 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal consistency and test-retest reliability of PCDQOL
Number of subjects: 220
Study 33410736 — intervention group
Group type: EXPERIMENTAL
Intervention: Z-drugs
Number of subjects: 6809
Study 33410736 — intervention group
Group type: COMPARATOR
Intervention: Control (no Z-drugs)
Number of subjects: 6809
Study 32439979 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 616
Study 32439979 — intervention group
Group type: COMPARATOR
Intervention: Dasatinib
Number of subjects: 616
Study 32439979 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib (female patients)
Number of subjects: 616
Study 34410749 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Metacognitive Reflection and Insight Therapy (MERIT)
Number of subjects: 0
Study 34410749 — intervention group
Group type: COMPARATOR
Intervention: Standard Metacognitive Reflection and Insight Therapy (MERIT)
Number of subjects: 0
Study 34815011 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational pain self-management intervention (6-week duration, including education, skills building, and nurse coaching)
Number of subjects: 28
Study 34815011 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse support during the intervention
Number of subjects: 28
Study 34815011 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative learning experiences post-RCT
Number of subjects: 28
Study 34815011 — intervention group
Group type: EXPERIMENTAL
Intervention: Data integration of quantitative and qualitative findings
Number of subjects: 28
Study 32375328 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency group (LF group) doing two longer interval sessions per week
Number of subjects: 15
Study 32375328 — intervention group
Group type: COMPARATOR
Intervention: High-frequency group (HF group) doing four short interval sessions per week
Number of subjects: 15
Study 35618372 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior Support Coaching for Paraprofessional Model (BSC-P)
Number of subjects: 259
Study 35618372 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 259
Study 34841124 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor physical therapy (PFPT)
Number of subjects: 140
Study 34841124 — intervention group
Group type: COMPARATOR
Intervention: Postponed treatment of PFPT (Control)
Number of subjects: 140
Study 32423255 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit Smoothie (FS)
Number of subjects: 25
Study 32423255 — intervention group
Group type: COMPARATOR
Intervention: Cereal and Milk (CM)
Number of subjects: 25
Study 32436173 — intervention group
Group type: COMPARATOR
Intervention: SRP + saline (Group 1)
Number of subjects: 96
Study 32436173 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + HA gel (Group 2)
Number of subjects: 96
Study 32436173 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + HA mouth rinse (Group 3)
Number of subjects: 96
Study 32436173 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + HA mouth rinse + HA gingival gel (Group 4)
Number of subjects: 96
Study 35168289 — intervention group
Group type: EXPERIMENTAL
Intervention: MSCs in fibrin (1 million cells/cm2 of wound bed surface)
Number of subjects: 11
Study 35168289 — intervention group
Group type: COMPARATOR
Intervention: Fibrin spray alone
Number of subjects: 11
Study 35168289 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 11
Study 33632136 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting early isolated distal deep vein thrombosis (IDDVT)
Number of subjects: 647
Study 35060116 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily aroma (sweet orange essential oil)
Number of subjects: 109
Study 35060116 — intervention group
Group type: EXPERIMENTAL
Intervention: Aroma every other day (sweet orange essential oil)
Number of subjects: 109
Study 35060116 — intervention group
Group type: COMPARATOR
Intervention: No aroma (control)
Number of subjects: 109
Study 33496829 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined deep learning model
Number of subjects: 384
Study 33496829 — intervention group
Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 384
Study 33496829 — intervention group
Group type: COMPARATOR
Intervention: DL image model
Number of subjects: 384
Study 33496829 — intervention group
Group type: COMPARATOR
Intervention: BI-RADS approach
Number of subjects: 384
Study 33496829 — intervention group
Group type: COMPARATOR
Intervention: Combined deep learning model vs senior radiologists
Number of subjects: 384
Study 33496829 — intervention group
Group type: COMPARATOR
Intervention: Combined deep learning model vs junior radiologists
Number of subjects: 384
Study 33496829 — intervention group
Group type: COMPARATOR
Intervention: AI assistance for junior radiologists
Number of subjects: 384
Study 33496829 — intervention group
Group type: COMPARATOR
Intervention: Interobserver agreement
Number of subjects: 384
Study 34836700 — intervention group
Group type: EXPERIMENTAL
Intervention: ER10 (light-curing for 10 s)
Number of subjects: 35
Study 34836700 — intervention group
Group type: EXPERIMENTAL
Intervention: ER40 (light-curing for 40 s)
Number of subjects: 35
Study 34836700 — intervention group
Group type: EXPERIMENTAL
Intervention: SE10 (light-curing for 10 s)
Number of subjects: 35
Study 32169321 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyelid warming mask (EWM) applied for 30 min before bedtime daily for 4 weeks
Number of subjects: 81
Study 32169321 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial tears administered as a single-use every day as needed for 4 weeks
Number of subjects: 81
Study 32169321 — intervention group
Group type: COMPARATOR
Intervention: Control group maintained normal lifestyle without treatment
Number of subjects: 81
Study 32460460 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir plus tenofovir (ETV+TDF), n=45
Number of subjects: 91
Study 32460460 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine/telbivudine plus adefovir (LAM/LdT+ADV), n=46
Number of subjects: 91
Study 32460460 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 91
Study 35986390 — intervention group
Group type: EXPERIMENTAL
Intervention: FX06 (2 × 200 mg per day) administered intravenously for 5 consecutive days
Number of subjects: 306
Study 35986390 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered intravenously for 5 consecutive days
Number of subjects: 306
Study 35986390 — intervention group
Group type: EXPERIMENTAL
Intervention: FX06
Number of subjects: 306
Study 34319506 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture with electro-acupuncture (EA) for 16 weeks
Number of subjects: 54
Study 34319506 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture for 16 weeks
Number of subjects: 54
Study 32131082 — intervention group
Group type: EXPERIMENTAL
Intervention: Early exercise regimes
Number of subjects: 115
Study 32131082 — intervention group
Group type: COMPARATOR
Intervention: Control (no early exercise regimes)
Number of subjects: 115
Study 33875631 — intervention group
Group type: EXPERIMENTAL
Intervention: hsa_circ_0021739 overexpression
Number of subjects: 53
Study 33875631 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study 33875631 — intervention group
Group type: EXPERIMENTAL
Intervention: hsa_circ_0021739 expression
Number of subjects: 53
Study 33218566 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates training for 8 weeks (three sessions of 60 min)
Number of subjects: 19
Study 33218566 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Pilates training)
Number of subjects: 19
Study 36087611 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilobelimab (800 mg intravenously for a maximum of six doses on days 1, 2, 4, 8, 15, and 22)
Number of subjects: 368
Study 36087611 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching placebo with standard of care)
Number of subjects: 368
Study 36087611 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilobelimab (in predefined analysis without site-stratification)
Number of subjects: 368
Study 36087611 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilobelimab
Number of subjects: 368
Study 33215600 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant anthracycline-taxane-based chemotherapy followed by endocrine therapy
Number of subjects: 241
Study 36299885 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX 200 μg combined with sufentanil 150 μg for PCA
Number of subjects: 210
Study 36299885 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX 400 μg combined with sufentanil 150 μg for PCA
Number of subjects: 210
Study 36299885 — intervention group
Group type: COMPARATOR
Intervention: DEX 0 μg combined with sufentanil 150 μg for PCA
Number of subjects: 210
Study 32607683 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 µM of DPI (diphenyleneiodonium)
Number of subjects: 40
Study 32607683 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 nM of PMA (phorbol 12‐myristate 13‐acetate)
Number of subjects: 40
Study 32607683 — intervention group
Group type: COMPARATOR
Intervention: Ham's F10 (control)
Number of subjects: 40
Study 32607683 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% DMSO (vehicle)
Number of subjects: 40
Study 35638321 — intervention group
Group type: EXPERIMENTAL
Intervention: taVNS (30-min stimulation via tragus)
Number of subjects: 54
Study 35638321 — intervention group
Group type: COMPARATOR
Intervention: sham stimulation (30-min stimulation via earlobe)
Number of subjects: 54
Study 34556563 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended learning (individual preparation with a course handbook and videoclips, plus a single face-to-face session)
Number of subjects: 163
Study 34556563 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face instruction (2 face-to-face sessions)
Number of subjects: 163
Study 32916658 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (n = 14)
Number of subjects: 27
Study 32916658 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 27
Study 32916658 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Cr and placebo)
Number of subjects: 27
Study 34331752 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure therapy at the Shen Men point and endocrine point bilaterally
Number of subjects: 58
Study 34331752 — intervention group
Group type: COMPARATOR
Intervention: Sham acupressure at a sham point bilaterally
Number of subjects: 58
Study 33430844 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-limb focussed intervention
Number of subjects: 27
Study 33430844 — intervention group
Group type: COMPARATOR
Intervention: Trunk-focussed intervention
Number of subjects: 27
Study 32702774 — intervention group
Group type: EXPERIMENTAL
Intervention: Complicated grief assessment in elderly individuals who experienced grief
Number of subjects: 247
Study 32702774 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of CG prevalence based on demographic factors
Number of subjects: 247
Study 32702774 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of CG prevalence based on deceased's characteristics
Number of subjects: 247
Study 32702774 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of CG prevalence in depressed vs non-depressed participants
Number of subjects: 247
Study 32702774 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender comparison in CG incidence
Number of subjects: 247
Study 32702774 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression severity comparison in CG incidence
Number of subjects: 247
Study 34311754 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based HIV counselling and testing (CBCT) platforms for PrEP initiation
Number of subjects: 480
Study 34311754 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence support interventions
Number of subjects: 480
Study 34311754 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative investigations
Number of subjects: 480
Study 34311754 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost and scalability evaluations
Number of subjects: 480
Study 32172521 — intervention group
Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate gel 0.38%
Number of subjects: 0